CLINICAL_TRIALS
trial_result
· 2024-08-22
Clinical Trial Update: A Study of ANX009 in Adult Participants With Lupus Nephritis [Phase 1]
Summary
A Phase 1 study of ANX009 in adults with lupus nephritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Annexon, Inc. | Conditions: Lupus Nephritis | Phase 1 | Status: COMPLETED